BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Serra G, Demontis F, Serra F, De Chiara L, Spoto A, Girardi P, Vidotto G, Serra G. Memantine: New prospective in bipolar disorder treatment. World J Psychiatr 2014; 4(4): 80-90 [PMID: 25540723 DOI: 10.5498/wjp.v4.i4.80]
URL: https://www.wjgnet.com/2220-3206/full/v4/i4/80.htm
Number Citing Articles
1
Giuseppe Quaranta, Angelo Giovanni Icro Maremmani, Giulio Perugi. Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner SyndromeCase Reports in Psychiatry 2015; 2015: 1 doi: 10.1155/2015/273192
2
Xiao-Ting Huang, Shao-Jie Yue, Chen Li, Jia Guo, Yan-Hong Huang, Jian-Zhong Han, Dan-Dan Feng, Zi-Qiang Luo. Antenatal blockade of N-methyl-D-aspartate receptors by Memantine reduces the susceptibility to diabetes induced by a high-fat diet in rats with intrauterine growth restriction†Biology of Reproduction 2017; 96(5): 960 doi: 10.1095/biolreprod.116.145011
3
Erin T Carey, Sawsan As-Sanie. New developments in the pharmacotherapy of neuropathic chronic pelvic painFuture Science OA 2016; 2(4): FSO148 doi: 10.4155/fsoa-2016-0048
4
Erin T. Carey, Sara R. Till, Sawsan As-Sanie. Pharmacological Management of Chronic Pelvic Pain in WomenDrugs 2017; 77(3): 285 doi: 10.1007/s40265-016-0687-8
5
An excessive increase in glutamate contributes to glucose-toxicity in β-cells via activation of pancreatic NMDA receptors in rodent diabetesScientific Reports 2017; 7(1) doi: 10.1038/srep44120
6
Ana Maria Orellana, Paula Fernanda Kinoshita, Jacqueline Alves Leite, Elisa Mitiko Kawamoto, Cristoforo Scavone. Cardiotonic Steroids as Modulators of NeuroinflammationFrontiers in Endocrinology 2016; 7 doi: 10.3389/fendo.2016.00010
7
Francesca Demontis, Gino Serra. Failure of memantine to “reverse” quinpirole-induced hypomotilityWorld Journal of Psychiatry 2016; 6(2): 215-220 doi: 10.5498/wjp.v6.i2.215
8
Ana Hategan, James A. Bourgeois. Donepezil-associated manic episode with psychotic features: a case report and review of the literatureGeneral Hospital Psychiatry 2016; 38: 115.e1 doi: 10.1016/j.genhosppsych.2015.09.004
9
Hiroki Kawai, Manabu Takaki, Shinji Sakamoto, Takashi Shibata, Ayaka Tsuchida, Bunta Yoshimura, Yuji Yada, Namiko Matsumoto, Kota Sato, Koji Abe, Yuko Okahisa, Yoshiki Kishi, Soshi Takao, Ko Tsutsui, Takashi Kanbayashi, Keiko Tanaka, Norihito Yamada. Anti-NMDA-receptor antibody in initial diagnosis of mood disorderEuropean Neuropsychopharmacology 2019; 29(9): 1041 doi: 10.1016/j.euroneuro.2019.07.137
10
Ignazia Mocci, Maria Antonietta Casu, Valeria Sogos, Anna Liscia, Rossella Angius, Francesca Cadeddu, Maura Fanti, Patrizia Muroni, Giuseppe Talani, Andrea Diana, Maria Collu, Maria Dolores Setzu. Effects of memantine on mania‐like phenotypes exhibited by Drosophila Shaker mutantsCNS Neuroscience & Therapeutics 2023; 29(7): 1750 doi: 10.1111/cns.14145
11
Fei Wang, Zhirong Zou, Yi Gong, Dong Yuan, Xun Chen, Tao Sun. Regulation of Human Brain Microvascular Endothelial Cell Adhesion and Barrier Functions by MemantineJournal of Molecular Neuroscience 2017; 62(1): 123 doi: 10.1007/s12031-017-0917-x
12
Mauro Giovanni Carta, Goce Kalcev, Michele Fornaro, Antonio Egidio Nardi. Novel experimental and early investigational drugs for the treatment of bipolar disorderExpert Opinion on Investigational Drugs 2021; 30(11): 1081 doi: 10.1080/13543784.2021.2000965
13
Chiara Montemitro, Alexandra Angebrandt, Tzu-Yun Wang, Mauro Pettorruso, Osama A. Abulseoud. Mechanistic insights into the efficacy of memantine in treating certain drug addictionsProgress in Neuro-Psychopharmacology and Biological Psychiatry 2021; 111: 110409 doi: 10.1016/j.pnpbp.2021.110409
14
Vahid Shafiei-Irannejad, Samin Abbaszadeh, Paul M.L. Janssen, Hamid Soraya. Memantine and its benefits for cancer, cardiovascular and neurological disordersEuropean Journal of Pharmacology 2021; 910: 174455 doi: 10.1016/j.ejphar.2021.174455
15
Kate M. Chitty, Jim Lagopoulos, Ian B. Hickie, Daniel F. Hermens. Alcohol use in bipolar disorder: A neurobiological model to help predict susceptibility, select treatments and attenuate cortical insultNeuroscience & Biobehavioral Reviews 2015; 56: 193 doi: 10.1016/j.neubiorev.2015.07.004
16
Jin-Chen Yang, Annette Rodriguez, Ashley Royston, Yu-Qiong Niu, Merve Avar, Ryan Brill, Christa Simon, Jim Grigsby, Randi J. Hagerman, John M. Olichney. Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled TrialScientific Reports 2016; 6(1) doi: 10.1038/srep21719
17
Grigorios N. Karakatsoulis, Konstantinos N. Fountoulakis. Glutamate and Neuropsychiatric Disorders2022; : 261 doi: 10.1007/978-3-030-87480-3_8
18
I. S. Preobrazhenskaya. Cognitive impairment and depressionMeditsinskiy sovet = Medical Council 2023; (21): 34 doi: 10.21518/ms2023-246
19
Juliana C Corrêa-Velloso, Maria CB Gonçalves, Yahaira Naaldijk, Ágatha Oliveira-Giacomelli, Micheli M Pillat, Henning Ulrich. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approachesProgress in Neuro-Psychopharmacology and Biological Psychiatry 2018; 80: 34 doi: 10.1016/j.pnpbp.2017.04.033
20
Gustavo de Souza Pessôa, Jemmyson Romário de Jesus, Tiago Santana Balbuena, Marco Aurélio Zezzi Arruda. Metallomics‐based platforms for comparing the human blood serum profiles between bipolar disorder and schizophrenia patientsRapid Communications in Mass Spectrometry 2020; 34(S3) doi: 10.1002/rcm.8698
21
Nicola Veronese, Marco Solmi, Claudio Luchini, Ru-Band Lu, Brendon Stubbs, Leonardo Zaninotto, Christoph U. Correll. Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensionsJournal of Affective Disorders 2016; 197: 268 doi: 10.1016/j.jad.2016.03.034
22
Pernille Bøttger, Simon Glerup, Bodil Gesslein, Nina B. Illarionova, Toke J. Isaksen, Anders Heuck, Bettina H. Clausen, Ernst-Martin Füchtbauer, Jan B. Gramsbergen, Eli Gunnarson, Anita Aperia, Martin Lauritzen, Kate L. Lambertsen, Poul Nissen, Karin Lykke-Hartmann. Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse modelScientific Reports 2016; 6(1) doi: 10.1038/srep22047